Aspirin can reduce the risk of cancer — and scientists are starting to understand why
New clinical trials and laboratory research over the past decade indicate that regular low-dose aspirin can cut the risk of certain cancers and reduce recurrence, especially in genetically vulnerable groups. Landmark randomized studies led by teams in the UK and Sweden found roughly a halving of colorectal cancer incidence or recurrence in people taking aspirin … Read more